These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Troubleshooting an isolate prolongation of activated partial thromboplastin time in a patient with acute myocardial infarction-a paradigmatic case report. Poli G; Castiglioni P; Montagnana M; Favaloro EJ; Lippi G Ann Transl Med; 2016 Nov; 4(21):426. PubMed ID: 27942517 [TBL] [Abstract][Full Text] [Related]
26. [Severe prekallikrein deficiency due to a compound heterozygosis in the KLKB1-gene]. Maak B; Kochhan L; Heuchel P; Jenderny J Hamostaseologie; 2009 May; 29(2):187-9. PubMed ID: 19404525 [TBL] [Abstract][Full Text] [Related]
27. Prolonged activated partial thromboplastin time with no clear explanation. Nakav S; Blickstein D; Raanani P; Rabizadeh E; Spectre G Blood Coagul Fibrinolysis; 2020 Apr; 31(3):225-228. PubMed ID: 31990752 [TBL] [Abstract][Full Text] [Related]
28. Prekallikrein deficiency in a dog. Chinn DR; Dodds WJ; Selcer BA J Am Vet Med Assoc; 1986 Jan; 188(1):69-71. PubMed ID: 3632973 [TBL] [Abstract][Full Text] [Related]
29. Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and Cys529Tyr). Lombardi AM; Sartori MT; Cabrio L; Fadin M; Zanon E; Girolami A Thromb Haemost; 2003 Dec; 90(6):1040-5. PubMed ID: 14652634 [TBL] [Abstract][Full Text] [Related]
30. Hageman factor deficiency presentation and implications for management. Harper K; Friedland ML Conn Med; 1992 Sep; 56(9):469-71. PubMed ID: 1424610 [TBL] [Abstract][Full Text] [Related]
31. A patient with a prolonged activated partial thromboplastin time and a deep intracerebral haemorrhage. Schindhelm RK; Wondergem MJ; Admiraal J; Nap G; Boekel ET; Hani L Case Rep Neurol; 2012 May; 4(2):131-6. PubMed ID: 22949911 [TBL] [Abstract][Full Text] [Related]
33. Prekallikrein deficiency in a dog. Okawa T; Yanase T; Shimokawa Miyama T; Hiraoka H; Baba K; Tani K; Okuda M; Mizuno T J Vet Med Sci; 2011 Jan; 73(1):107-11. PubMed ID: 20736516 [TBL] [Abstract][Full Text] [Related]
35. Properties of sulfatides in factor-XII-dependent contact activation. Tans G; Griffin JH Blood; 1982 Jan; 59(1):69-75. PubMed ID: 6914902 [TBL] [Abstract][Full Text] [Related]
36. [Disorders in the contact phase system of blood coagulation as a cause of increased partial thromboplastin time]. Siegert G; Plat M Z Gesamte Inn Med; 1988 May; 43(9):228-31. PubMed ID: 3407236 [TBL] [Abstract][Full Text] [Related]
37. Initiation of contact activation by sulfatides. Tans G; Griffin JH Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464 [TBL] [Abstract][Full Text] [Related]
38. [Acute lung injury as a consequence of fresh frozen plasma administration in a patient with factor XII deficiency]. San Juan-Álvarez M; Sánchez-Zamora P; de la Flor-Robledo M Rev Esp Anestesiol Reanim; 2014 Oct; 61(8):446-50. PubMed ID: 24252352 [TBL] [Abstract][Full Text] [Related]
39. Prolonged Activated Clotting Time Immediately Prior to Open Cardiac Surgery. Baker SM; Kiefer A; Carollo DS; Warrier RP Ochsner J; 2018; 18(4):423-424. PubMed ID: 30559632 [TBL] [Abstract][Full Text] [Related]
40. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation]. Vogel G; Stürzebecher J; Klessen C; Lauten G Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]